AMA Update

2022 Nobel Peace Prize nominee Peter Hotez, MD, PhD, discusses his coronavirus vaccine, CorbeVax, as well as his Paxlovid rebound infection experience, and growing concerns around monkeypox. American Medical Association CXO Todd Unger hosts. Dr. Peter Hotez is dean of the National School of Tropical Medicine at Baylor College of Medicine, and co-director of the Texas Children’s Hospital Center for Vaccine Development in Houston.

COVID-19 boosters this September, CDC designates monkeypox as nationally notifiable condition as outbreak continues, and new CPT codes added, as covered by AMA Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. American Medical Association CXO Todd Unger hosts.

Novavax vaccine dose, delivery, storage, side effects—and all the details doctors need to know with Sandra Fryhofer, MD, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup. American Medical Association CXO Todd Unger hosts. AMA COVID-19 resource center for physicians: http://ama-assn.org/covid-19

AMA Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH, details summer spike of COVID-19 cases driven by the highly transmissible Omicron BA.5 subvariant. Also covering Novavax news, as well as monkeypox cases and stats—including the World Health Organization (WHO) declaring it a global health emergency. American Medical Association CXO Todd Unger hosts.

AMA Director of Science, Medicine and Public Health Andrea Garcia on the latest from the FDA and CDC, covering Novavax vaccine updates, getting a second booster shot, and continued spread of monkeypox across the United States. American Medical Association CXO Todd Unger hosts. • CDC Emergency Operations Center contact phone number (monkeypox): 770-488-7100 • Information for Healthcare Providers on Obtaining and Using TPOXX (Tecovirimat) for Treatment of Monkeypox: https://www.cdc.gov/poxvirus/monkeypox/clinicians/obtaining-tecovirimat.html

Two experts from the CDC’s Division of High-Consequence Pathogens & Pathology in Atlanta, Caroline Schrodt, MD, and Jennifer McQuiston, DVM, talk with American Medical Association CXO Todd Unger about what physicians need to know about monkeypox, including the latest numbers, how it's spread, vulnerable populations, common symptoms, and available treatments and testing. For up-to-date information visit the CDC’s monkeypox website: www.cdc.gov/poxvirus

The latest on Omicron subvariants, delays in state-by-state COVID case reporting and more with AMA Director of Science, Medicine and Public Health, Andrea Garcia JD, MPH. American Medical Association CXO, Todd Unger hosts.

On vaccinating his 3-year-old son: Jesse Ehrenfeld, MD, MPH, a practicing anesthesiologist in Milwaukee and the AMA’s new president-elect, shares his family's vaccine experience with American Medical Association CXO Todd Unger, as well as advice for parents of young kids and tips for doctors on answering questions from vaccine-hesitant parents. Find COVID vaccine locations near you: https://www.vaccines.gov/search/

Omicron summer surges, progress on booster shots for fall, kid's COVID vaccine rollout, monkeypox vaccines distributed and more discussed by AMA Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH and American Medical Association CXO, Todd Unger.

AMA CXO Todd Unger discusses the latest on COVID vaccines for fall with AMA Director of Science, Medicine and Public Health Andrea Garcia, JD, MPH. Also covering the vaccine rollout for kids under 5, as well as AMA's statements on the U.S. Supreme Court decisions regarding firearm violence and overturning Roe v. Wade.

AMA CXO Todd Unger discusses the latest on COVID vaccines for kids under 5 with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering progress on Moderna's and Pfizer's EUAs, and identifying questions parents might have for physicians about getting their kids vaccinated.

AMA CXO Todd Unger discusses FDA timeline on Pfizer & Moderna vaccines for the youngest children with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the FDA advisory committee's recommendations for kids ages 6 to 17, news on a possible booster for fall, as well as the lifting of testing requirements for international travel to the U.S.

AMA CXO Todd Unger reviews the timeline for COVID vaccines for kids under 5 with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering COVID case numbers, what to expect this summer, how and why you should report positive at-home tests, as well as an increase in monkeypox cases in the U.S.

Hear the latest on who should receive the fourth dose of the COVID-19 booster—and when—and whether we’ll be seeing a vaccine for younger children soon. Susan R. Bailey, MD, immediate past president, AMA welcomes Peter Marks, MD, PhD, Director of the Center for Biologics Evaluation and Research at the Food and Drug Administration (FDA), addressing a host of hot topics related to the fourth dose booster vaccine and provide updates on pediatric vaccine safety data.

On this episode, Emily Volk, MD, FCAP, president of the College of American Pathologists, talks about the ins and outs of COVID-19 testing; knowing when to test, what test to take, and other pressing questions patients may have.

AMA CXO Todd Unger reviews COVID-19 case trends coming out of the long weekend with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering Paxlovid treatments and "rebound infections," monkeypox infections, and the AMA's statement on the Texas elementary shootings that have devastated our nation.

AMA CXO Todd Unger reviews the latest on vaccines for children ages 6 months through 4 years, as well as boosters for 5-11 year olds with AMA Director of Science, Medicine and Public Health, Andrea Garcia, JD, MPH. Also covering CDC's recommendation on a second booster shot for people 50 or older, and the latest on the monkeypox outbreak.

AMA CXO Todd Unger discusses what physicians and patients need to know about Paxlovid with John Farley, MD, MPH, director of the Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs at the FDA. For more information on Paxlovid from the FDA, visit: https://www.fda.gov/drugs/news-events-human-drugs/fda-updates-paxlovid-health-care-providers

AMA CXO Todd Unger and Andrea Garcia, AMA's director of science, medicine and public health, discuss the grim milestone of one million COVID deaths in the U.S. Also covering rising cases—especially in the Northeast and Midwest, where daily case reports are higher now than at the peak of 2021's summer Delta surge. As well as news from last week's second global COVID-19 vaccination summit.

AMA CXO Todd Unger discusses the status of Covid vaccines for kids under 5 with Paul Offit, MD, director of the Vaccine Education Center and an attending physician in the Division of Infectious Diseases at Children's Hospital of Philadelphia. Dr. Offit is also a member of the FDA’s vaccine advisory committee.

Get your news from the physicians, scientists and others leading the pandemic response. Subscribe now on your favorite podcast platform.

Watch the full webinar here: https://www.ama-assn.org/delivering-care/public-health/covid-19-fourth-dose-boosters-and-vaccine-update-peter-marks-md

AMA CXO Todd Unger discusses the latest Johnson & Johnson COVID vaccine news with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering a newly released estimate for COVID-19 related deaths using excess mortality, as well as summer spikes of coronavirus cases, hospitalizations, and that masking up in airports or high-risk settings continues to reduce chances of COVID infection.

On May 9th, AMA's immediate past president, Susan Bailey, MD, will host the live webinar: "Fourth dose boosters and pediatric vaccine update with Dr. Peter Marks." Register for the AMA's webinar: https://www.ama-assn.org/delivering-care/public-health/covid-19-webinar-series-fourth-dose-boosters-and-pediatric-vaccines

How will our nation—and America’s physicians—move beyond this pandemic? Tune in to hear expert physician perspectives on what lies ahead—and to learn how to prepare yourself, your practice and your patients for what’s next. Our physician guests include: Georges Benjamin, MD, Executive director, American Public Health Association; Céline Gounder, MD, Senior fellow and editor-at-large for Public Health, Kaiser Family Foundation and Kaiser Health News; clinical associate professor, Medicine and Infectious Diseases, New York University; Stephen Parodi, MD, executive vice president, External Affairs, Communications, and Brand, The Permanente Federation; associate executive director, The Permanente Medical Group

AMA CXO Todd Unger discusses COVID data reporting changes and strengthening public health infrastructure with Marcus Plescia, MD, MPH, the chief medical officer of the Association of State and Territorial Health Officials (ASTHO) in Atlanta.

AMA CXO Todd Unger reviews COVID-19 case numbers and the legal battle over mask mandates with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the CDC's latest health alert for COVID therapies, as well as the FDA's approval of Remdesivir to treat pediatric coronavirus patients (kids 12 and younger). More information on the CDC's health alert: https://emergency.cdc.gov/han/2022/han00463.asp

AMA CXO Todd Unger reviews changes to the national mask mandate with AMA Director of Science, Medicine and Public Health Andrea Garcia, including which airlines no longer require masks and the cities still enforcing mask mandates on public transit. Also covering the emerging subvariants BA.2.12 and BA.2.12.1, a new COVID breath test, and why Americans over 60 should get a second booster shot.

AMA CXO Todd Unger is joined by Tom Frieden, MD, MPH, former director of the CDC and president and CEO of Resolve to Save Lives in New York to discuss how we can use lessons from the past two years to strengthen our public health system and pandemic response.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering updates from FDA’s vaccine advisory committee meeting regarding a revised version of the COVID vaccine for fall, the FDA suspending use of a monoclonal antibody drug by GlaxoSmithKline known as sotrovimab to treat high-risk COVID-19 patients in the U.S. because it’s unlikely to be effective against BA.2, and a clinical trial published in NEJM confirms that the anti-parasitic drug, ivermectin, showed no sign of alleviating COVID.

AMA CXO Todd Unger discusses the latest research on long COVID with Akiko Iwasaki, PhD, the Sterling Professor of Immunobiology at Yale University and a principal investigator at the Howard Hughes Medical Institute.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the spread of the BA2 variant, Medicare paying for at-home COVID tests, as well as the latest from the FDA and CDC regarding who may get a second COVID booster shot.

For more resources and access to “A Physician Guide to Keeping Your Practice Open During the Ongoing COVID-19 Pandemic,” visit: ama-assn.org/KeepPracticeOpenGuide

AMA CXO Todd Unger reflects on #SaveYourVisionMonth with David Aizuss, MD, an ophthalmologist in Los Angeles and an AMA trustee, who shares what physicians want you to know about how the pandemic may be affecting your eye health and the importance of regular eye care from a physician.

AMA CXO Todd Unger reviews COVID-19 trending topics and news related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health, Andrea Garcia. Also covering the FDA's authorization of a second booster shot, as well as changes in COVID treatments and therapies. Additionally, uninsured patients may have to pay high prices out-of-pocket for COVID tests and vaccinations due to lack of federal funding and stalled budget approval.

AMA CXO Todd Unger reviews COVID-19 news and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering what we know about the BA.2 Omicron subvariant, if a new surge is coming soon, the latest on booster shots and changing data collection on the pandemic.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering state-wide mandates lifting for masks in school, and the latest developments on when a COVID vaccine will be available for kids under 5.

AMA CXO Todd Unger talks with AMA President Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., who shares five actions we can take now to fix our ailing health care system and rebuild trust.

AMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the government's newly released COVID response strategy and how it will take the nation out of crisis mode, the CDC's scaled back contact tracing efforts and the U.S. Surgeon General's renewed push to fight misinformation online.

AMA CXO Todd Unger talks with Stephen Parodi, MD, the executive vice president of external affairs, communications and brand at The Permanente Federation, and associate executive director for The Permanente Medical Group in Oakland, Calif., about pandemic vs. endemic and what that shift will mean for our COVID-19 response.

AMA CXO Todd Unger reviews COVID-19 case numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering new data from CDC studies, understanding community risk and finding your local COVID-19 Community Level, as well as positive long-lasting effects of COVID booster shots. Access the Centers for Disease Control and Prevention's "COVID-19 by County" tracker here: https://www.cdc.gov/coronavirus/2019-ncov/your-health/covid-by-county.html

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the latest on coronavirus treatments, including Merk's COVID pill, as well as research outlining the positive effects of getting vaccinated during pregnancy.

In part three of this three-part series, Aimee Hodowanec, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what physicians need to know about Molnupiravir as treatment for COVID-19.

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering the FDA's pivot to wait for more data on vaccines for kids under 5, and what new data from the CDC tells us about booster shots.

In part two of this three-part series, Stephanie Troy, MD, senior medical officer, Division of Antivirals, Office of Infectious Disease in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA, discusses what to know about Paxlovid as treatment for COVID-19.

AMA CXO Todd Unger dives into new developments from ACIP's emergency meeting on Feb. 4 with Dr. Sandra Fryhofer, AMA’s liaison to the Advisory Committee on Immunization Practices (ACIP), and a member of ACIP’s COVID-19 Vaccine Workgroup.

AMA president Gerald Harmon, MD, welcomes experts from the U.S. Food and Drug Administration (FDA) to discuss what prescribers need to know about COVID-19 therapeutic drugs, Paxlovid and Molnupiravir. Alternative treatment options for high-risk outpatients with mild-moderate COVID-19 are also discussed. Guest: John Farley, MD, MPH, director, Office of Infectious Diseases in the Center for Drug Evaluation and Research’s Office of New Drugs, FDA

AMA CXO Todd Unger reviews COVID-19 vaccine numbers and trending topics related to the pandemic over the past week with AMA Director of Science, Medicine and Public Health Andrea Garcia. Also covering new data coming from the CDC solidifying wearing high-quality N95 and KN95 masks provide the best chance of avoiding infection, as well as the addition of a new data point to the CDC’s COVID data tracker.

AMA CXO Todd Unger is joined by the AMA’s president, Gerald Harmon, MD, a family medicine specialist in Pawleys Island, S.C., who shares new information and big takeaways about therapeutics for COVID-19 after his recent conversation with three physician leaders from the FDA.

AMA CXO Todd Unger talks with David Rubin, MD, director of PolicyLab at Children’s Hospital of Philadelphia and a professor of pediatrics at the Perelman School of Medicine at the University of Pennsylvania, about his team's nationally recognized COVID-19 forecasting model and how it informs new guidance for K-12 educational settings aimed at keeping kids in school.